ethacridine has been researched along with pci 32765 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, DL; Datti, A; Gronda, M; Hurren, R; Lin, FH; MacLean, N; Minden, MD; Rotin, LE; Schimmer, AD; Slassi, M; Wang, X; Wrana, J | 1 |
1 other study(ies) available for ethacridine and pci 32765
Article | Year |
---|---|
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Apoptosis; Cell Line, Tumor; Drug Synergism; Drug Therapy, Combination; Ethacridine; Glycoside Hydrolases; Humans; Hydrolyzable Tannins; Jurkat Cells; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering | 2016 |